{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:50:56Z","timestamp":1785527456575,"version":"3.56.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CNS2022-135378"],"award-info":[{"award-number":["CNS2022-135378"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CPP2022-009522"],"award-info":[{"award-number":["CPP2022-009522"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014180","name":"Junta de Castilla y Le\u00f3n","doi-asserted-by":"publisher","award":["LE044P20"],"award-info":[{"award-number":["LE044P20"]}],"id":[{"id":"10.13039\/501100014180","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Methicillin-resistant\n                    <jats:italic>Staphylococcus aureus<\/jats:italic>\n                    (MRSA) remains a major clinical challenge, particularly intracellular MRSA infections are difficult to treat because antimicrobial agents must combine stability, host-cell access and bacterial target engagement. Cyclotides offer highly stable cyclic scaffolds for peptide engineering, but their use as intracellular antimicrobial protein inhibitors remains largely unexplored. Here, we engineered a cyclotide-grafted derivative of the antimicrobial peptide KTR by inserting it into the MCoTI-I scaffold, generating the cyclic construct MCo-KTR2. Molecular docking and molecular dynamics suggested potential interactions between MCo-KTR2 and the resistance-associated penicillin-binding protein PBP2a. Site-directed mutagenesis and fluorescence polarization assays indicated that specific residues contribute to binding in vitro. Although MCo-KTR2 displayed lower activity than linear KTR in standard MIC assays, cyclotide grafting increased serum stability by more than 30-fold and enhanced cellular uptake, colocalising with cytosolic\n                    <jats:italic>S. aureus<\/jats:italic>\n                    during infection. These properties were associated with improved activity against intracellular bacteria without detectable cytotoxicity or haemolytic activity. Furthermore, MCo-KTR2 showed higher antibacterial activity when combined with the membrane-active compound Visomitin as well as in combination with vancomycin and gentamicin. Together, these findings identify cyclotide grafting as a strategy to improve peptide stability and intracellular delivery, and support MCo-KTR2 as a scaffold for further optimization against intracellular MRSA infections.\n                  <\/jats:p>","DOI":"10.1186\/s43556-026-00519-z","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T07:09:31Z","timestamp":1785308971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Design of a cyclic peptide targeting intracellular Staphylococcus aureus"],"prefix":"10.1186","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4926-3891","authenticated-orcid":false,"given":"\u00c1lvaro","family":"Mourenza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Llano-Verdeja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Casta\u00f1era","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Vogelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Lorente-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Fern\u00e1ndez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena \u00c1.","family":"Ferrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennica","family":"Zaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas F.","family":"Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"Mateos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"de la Fuente-Nunez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Letek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"519_CR1","doi-asserted-by":"publisher","unstructured":"Collaborators GBDAR. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022;400(10369):2221\u201348. https:\/\/doi.org\/10.1016\/S0140-6736(22)02185-7.","DOI":"10.1016\/S0140-6736(22)02185-7"},{"issue":"10325","key":"519_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"RC Antimicrobial","year":"2022","unstructured":"Antimicrobial RC. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0.","journal-title":"Lancet"},{"key":"519_CR3","doi-asserted-by":"publisher","unstructured":"Collaborators GBDAR. Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199\u2013226. https:\/\/doi.org\/10.1016\/S0140-6736(24)01867-1.","DOI":"10.1016\/S0140-6736(24)01867-1"},{"key":"519_CR4","doi-asserted-by":"publisher","unstructured":"Lorente-Torres B, Llano-Verdeja J, Castanera P, Ferrero HA, Fernandez-Martinez S, Javadimarand F et al. Innovative Strategies in Drug Repurposing to Tackle Intracellular Bacterial Pathogens. Antibiotics (Basel). 2024;13(9). https:\/\/doi.org\/10.3390\/antibiotics13090834.","DOI":"10.3390\/antibiotics13090834"},{"key":"519_CR5","doi-asserted-by":"publisher","unstructured":"Brandquist ND, Kielian T. Immune dysfunction during S. aureus biofilm-associated implant infections: opportunities for novel therapeutic strategies. NPJ Biofilms Microbiomes. 2025;11(1):144. https:\/\/doi.org\/10.1038\/s41522-025-00782-y.","DOI":"10.1038\/s41522-025-00782-y"},{"issue":"7578","key":"519_CR6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nature16057","volume":"527","author":"SM Lehar","year":"2015","unstructured":"Lehar SM, Pillow T, Xu M, Staben L, Kajihara KK, Vandlen R, et al. Novel antibody-antibiotic conjugate eliminates intracellular S. aureus. Nature. 2015;527(7578):323\u20138. https:\/\/doi.org\/10.1038\/nature16057.","journal-title":"Nature"},{"key":"519_CR7","doi-asserted-by":"publisher","unstructured":"Mourenza A, Gil JA, Mateos LM, Letek M. Alternative Anti-Infective Treatments to Traditional Antibiotherapy against Staphylococcal Veterinary Pathogens. Antibiotics (Basel). 2020;9(10). https:\/\/doi.org\/10.3390\/antibiotics9100702.","DOI":"10.3390\/antibiotics9100702"},{"issue":"48","key":"519_CR8","doi-asserted-by":"publisher","first-page":"13195","DOI":"10.1021\/acs.jafc.9b05595","volume":"67","author":"SC Wu","year":"2019","unstructured":"Wu SC, Liu F, Zhu K, Shen JZ. Natural products that target virulence factors in antibiotic-resistant Staphylococcus aureus. J Agric Food Chem. 2019;67(48):13195\u2013211. https:\/\/doi.org\/10.1021\/acs.jafc.9b05595.","journal-title":"J Agric Food Chem"},{"key":"519_CR9","doi-asserted-by":"publisher","unstructured":"Bravo-Santano N, Behrends V, Letek M. Host-Targeted Therapeutics against Multidrug Resistant Intracellular Staphylococcus aureus. Antibiotics (Basel). 2019;8(4). https:\/\/doi.org\/10.3390\/antibiotics8040241.","DOI":"10.3390\/antibiotics8040241"},{"key":"519_CR10","doi-asserted-by":"publisher","unstructured":"Casta\u00f1era P, Llano-Verdeja J, Ferrero H\u00c1, Fern\u00e1ndez-Mart\u00ednez S, Lorente-Torres B, Pereira FJ et al. Host-directed microRNA-based intervention against intracellular Staphylococcus aureus: high-throughput screening identifies miR-4430, miR-147a, and miR-1249\u20135p as multifunctional antimicrobial candidates. Frontiers in Cellular and Infection Microbiology. 2026;16. https:\/\/doi.org\/10.3389\/fcimb.2026.1772100.","DOI":"10.3389\/fcimb.2026.1772100"},{"issue":"42","key":"519_CR11","doi-asserted-by":"publisher","first-page":"5975","DOI":"10.2174\/0929867325666180327105842","volume":"25","author":"RC Diniz","year":"2018","unstructured":"Diniz RC, Soares LW, Nascimento da Silva LC. Virtual screening for the development of new effective compounds against Staphylococcus aureus. Curr Med Chem. 2018;25(42):5975\u201385. https:\/\/doi.org\/10.2174\/0929867325666180327105842.","journal-title":"Curr Med Chem"},{"issue":"7","key":"519_CR12","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41551-024-01201-x","volume":"8","author":"F Wan","year":"2024","unstructured":"Wan F, Torres MDT, Peng J, de la Fuente-Nunez C. Deep-learning-enabled antibiotic discovery through molecular de-extinction. Nat Biomed Eng. 2024;8(7):854\u201371. https:\/\/doi.org\/10.1038\/s41551-024-01201-x.","journal-title":"Nat Biomed Eng"},{"issue":"6654","key":"519_CR13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1126\/science.adh1114","volume":"381","author":"F Wong","year":"2023","unstructured":"Wong F, de la Fuente-Nunez C, Collins JJ. Leveraging artificial intelligence in the fight against infectious diseases. Science. 2023;381(6654):164\u201370. https:\/\/doi.org\/10.1126\/science.adh1114.","journal-title":"Science"},{"key":"519_CR14","doi-asserted-by":"publisher","unstructured":"Santos-Junior CD, Torres MDT, Duan Y, Rodriguez Del Rio A, Schmidt TSB, Chong H et al. Discovery of antimicrobial peptides in the global microbiome with machine learning. Cell. 2024;187(14):3761\u201378 e16. https:\/\/doi.org\/10.1016\/j.cell.2024.05.013.","DOI":"10.1016\/j.cell.2024.05.013"},{"issue":"10","key":"519_CR15","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1039\/d3cb00015j","volume":"4","author":"A Mourenza","year":"2023","unstructured":"Mourenza A, Ganesan R, Camarero JA. Resistance is futile: targeting multidrug-resistant bacteria with de novo Cys-rich cyclic polypeptides. RSC Chem Biol. 2023;4(10):722\u201335. https:\/\/doi.org\/10.1039\/d3cb00015j.","journal-title":"RSC Chem Biol"},{"key":"519_CR16","doi-asserted-by":"publisher","unstructured":"Rosengren KJ, Daly NL, Plan MR, Waine C, Craik DJ. Twists, knots, and rings in proteins. Structural definition of the cyclotide framework. J Biol Chem. 2003;278(10):8606\u201316. https:\/\/doi.org\/10.1074\/jbc.M211147200.","DOI":"10.1074\/jbc.M211147200"},{"issue":"1","key":"519_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1042\/BCJ20180792","volume":"476","author":"D Chaudhuri","year":"2019","unstructured":"Chaudhuri D, Aboye T, Camarero JA. Using backbone-cyclized Cys-rich polypeptides as molecular scaffolds to target protein-protein interactions. Biochem J. 2019;476(1):67\u201383. https:\/\/doi.org\/10.1042\/BCJ20180792.","journal-title":"Biochem J"},{"key":"519_CR18","doi-asserted-by":"publisher","unstructured":"Koehbach J, Gani J, Hilpert K, Craik DJ. Comparison of a Short Linear Antimicrobial Peptide with Its Disulfide-Cyclized and Cyclotide-Grafted Variants against Clinically Relevant Pathogens. Microorganisms. 2021;9(1249). https:\/\/doi.org\/10.3390\/microorganisms9061249.","DOI":"10.3390\/microorganisms9061249"},{"issue":"49","key":"519_CR19","doi-asserted-by":"publisher","first-page":"12702","DOI":"10.1002\/chem.202101438","volume":"27","author":"R Ganesan","year":"2021","unstructured":"Ganesan R, Dughbaj MA, Ramirez L, Beringer S, Aboye TL, Shekhtman A, et al. Engineered cyclotides with potent broad in vitro and in vivo antimicrobial activity. Chemistry. 2021;27(49):12702\u20138. https:\/\/doi.org\/10.1002\/chem.202101438.","journal-title":"Chemistry"},{"issue":"5","key":"519_CR20","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00425-016-2562-y","volume":"244","author":"B Slazak","year":"2016","unstructured":"Slazak B, Kapusta M, Malik S, Bohdanowicz J, Kuta E, Malec P, et al. Immunolocalization of cyclotides in plant cells, tissues and organ supports their role in host defense. Planta. 2016;244(5):1029\u201340. https:\/\/doi.org\/10.1007\/s00425-016-2562-y.","journal-title":"Planta"},{"issue":"6","key":"519_CR21","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00726-023-03271-8","volume":"55","author":"TNT Ho","year":"2023","unstructured":"Ho TNT, Pham SH, Nguyen LTT, Nguyen HT, Nguyen LT, Dang TT. Insights into the synthesis strategies of plant-derived cyclotides. Amino Acids. 2023;55(6):713\u201329. https:\/\/doi.org\/10.1007\/s00726-023-03271-8.","journal-title":"Amino Acids"},{"key":"519_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/bs.abr.2015.08.006","volume":"76","author":"Y Li","year":"2015","unstructured":"Li Y, Bi T, Camarero JA. Chemical and biological production of cyclotides. Adv Bot Res. 2015;76:271\u2013303. https:\/\/doi.org\/10.1016\/bs.abr.2015.08.006.","journal-title":"Adv Bot Res"},{"issue":"4","key":"519_CR23","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1080\/07388551.2024.2412780","volume":"45","author":"MS Taghizadeh","year":"2025","unstructured":"Taghizadeh MS, Niazi A, Mirzapour-Kouhdasht A, Pereira EC, Garcia-Vaquero M. Enhancing cyclotide bioproduction: harnessing biological synthesis methods and various expression systems for large-scale manufacturing. Crit Rev Biotechnol. 2025;45(4):836\u201358. https:\/\/doi.org\/10.1080\/07388551.2024.2412780.","journal-title":"Crit Rev Biotechnol"},{"key":"519_CR24","doi-asserted-by":"publisher","unstructured":"Otero LH, Rojas-Altuve A, Llarrullb LI, Carrasco-L\u00f3pez C, Kumarasiri M, Lastochkin E et al. How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function. Proc Natl Acad Sci U S A. 2013;110(42):16808\u201313. https:\/\/doi.org\/10.1073\/pnas.1300118110.","DOI":"10.1073\/pnas.1300118110"},{"issue":"29","key":"519_CR25","doi-asserted-by":"publisher","first-page":"9791","DOI":"10.1021\/jacs.7b04881","volume":"139","author":"V Srisuknimit","year":"2017","unstructured":"Srisuknimit V, Qiao Y, Schaefer K, Kahne D, Walker S. Peptidoglycan cross-linking preferences of Staphylococcus aureus penicillin-binding proteins have implications for treating MRSA infections. J Am Chem Soc. 2017;139(29):9791\u20134. https:\/\/doi.org\/10.1021\/jacs.7b04881.","journal-title":"J Am Chem Soc"},{"key":"519_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2025.118376","volume":"130","author":"MW Shalaby","year":"2025","unstructured":"Shalaby MW, Abutaleb NS, Dokla EME, Elgammal Y, Liang HW, Serya RAT, et al. Tackling microbial resistance with 4H-chromen-4-one derivatives as a novel class of penicillin binding protein 2a inhibitors. Bioorg Med Chem. 2025;130:118376. https:\/\/doi.org\/10.1016\/j.bmc.2025.118376.","journal-title":"Bioorg Med Chem"},{"issue":"10","key":"519_CR27","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1093\/jac\/dkae241","volume":"79","author":"B Beadell","year":"2024","unstructured":"Beadell B, Yamauchi J, Wong-Beringer A. Comparative in vitro efficacy of antibiotics against the intracellular reservoir of Staphylococcus aureus. J Antimicrob Chemother. 2024;79(10):2471\u20138. https:\/\/doi.org\/10.1093\/jac\/dkae241.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"519_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202205301","volume":"10","author":"Q He","year":"2023","unstructured":"He Q, Yang Z, Zou Z, Qian M, Wang X, Zhang X, et al. Combating Escherichia coli O157:H7 with functionalized chickpea-derived antimicrobial peptides. Adv Sci. 2023;10(6):e2205301. https:\/\/doi.org\/10.1002\/advs.202205301.","journal-title":"Adv Sci"},{"issue":"5","key":"519_CR29","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1021\/acs.jafc.3c08241","volume":"72","author":"X Zhang","year":"2024","unstructured":"Zhang X, Ma P, Ismail BB, Yang Z, Zou Z, Suo Y, et al. Chickpea-derived modified antimicrobial peptides KTA and KTR inactivate Staphylococcus aureus via disrupting cell membrane and interfering with peptidoglycan synthesis. J Agric Food Chem. 2024;72(5):2727\u201340. https:\/\/doi.org\/10.1021\/acs.jafc.3c08241.","journal-title":"J Agric Food Chem"},{"issue":"W1","key":"519_CR30","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46(W1):W296\u2013303. https:\/\/doi.org\/10.1093\/nar\/gky427.","journal-title":"Nucleic Acids Res"},{"issue":"20","key":"519_CR31","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1093\/bioinformatics\/btu426","volume":"30","author":"E Krieger","year":"2014","unstructured":"Krieger E, Vriend G. YASARA view - molecular graphics for all devices - from smartphones to workstations. Bioinformatics. 2014;30(20):2981\u20132. https:\/\/doi.org\/10.1093\/bioinformatics\/btu426.","journal-title":"Bioinformatics"},{"key":"519_CR32","doi-asserted-by":"publisher","unstructured":"Krieger E, Joo K, Lee J, Lee J, Raman S, Thompson J et al. Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: Four approaches that performed well in CASP8. Proteins. 2009;77 Suppl 9(Suppl 9):114\u201322. https:\/\/doi.org\/10.1002\/prot.22570.","DOI":"10.1002\/prot.22570"},{"issue":"31","key":"519_CR33","doi-asserted-by":"publisher","first-page":"11623","DOI":"10.1021\/ja405108p","volume":"135","author":"Y Ji","year":"2013","unstructured":"Ji Y, Majumder S, Millard M, Borra R, Bi T, Elnagar AY, et al. In vivo activation of the p53 tumor suppressor pathway by an engineered cyclotide. J Am Chem Soc. 2013;135(31):11623\u201333. https:\/\/doi.org\/10.1021\/ja405108p.","journal-title":"J Am Chem Soc"},{"key":"519_CR34","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/978-1-0716-0434-2_16","volume":"2133","author":"MJ Campbell","year":"2020","unstructured":"Campbell MJ, Su J, Camarero JA. Recombinant Expression of Cyclotides Using Expressed Protein Ligation. Methods Mol Biol. 2020;2133:327\u201341. https:\/\/doi.org\/10.1007\/978-1-0716-0434-2_16.","journal-title":"Methods Mol Biol"},{"key":"519_CR35","doi-asserted-by":"crossref","unstructured":"Woods GL, Brown-Elliott BA, Conville PS, Desmond EP, Hall GS, Grace Lin GEP et al. Clinical and Laboratory Standards Institute. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes\u2014Second. Approved Standard M24-A2. 2011.","DOI":"10.1128\/9781555816728.ch73"},{"issue":"50","key":"519_CR36","doi-asserted-by":"publisher","first-page":"12519","DOI":"10.1002\/anie.201206749","volume":"51","author":"E Kuru","year":"2012","unstructured":"Kuru E, Hughes HV, Brown PJ, Hall E, Tekkam S, Cava F, et al. In situ probing of newly synthesized peptidoglycan in live bacteria with fluorescent D-amino acids. Angew Chem Int Ed Engl. 2012;51(50):12519\u201323. https:\/\/doi.org\/10.1002\/anie.201206749.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"11","key":"519_CR37","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1038\/s41596-024-01011-0","volume":"19","author":"RV Honorato","year":"2024","unstructured":"Honorato RV, Trellet ME, Jimenez-Garcia B, Schaarschmidt JJ, Giulini M, Reys V, et al. The HADDOCK2.4 web server for integrative modeling of biomolecular complexes. Nat Protoc. 2024;19(11):3219\u201341. https:\/\/doi.org\/10.1038\/s41596-024-01011-0.","journal-title":"Nat Protoc"},{"issue":"11","key":"519_CR38","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/nsb858","volume":"9","author":"D Lim","year":"2002","unstructured":"Lim D, Strynadka NC. Structural basis for the beta lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus. Nat Struct Biol. 2002;9(11):870\u20136. https:\/\/doi.org\/10.1038\/nsb858.","journal-title":"Nat Struct Biol"},{"key":"519_CR39","doi-asserted-by":"publisher","first-page":"1493165","DOI":"10.3389\/fchem.2024.1493165","volume":"12","author":"M Hussain","year":"2024","unstructured":"Hussain M, Kanwal N, Jahangir A, Ali N, Hanif N, Ullah O. Computational modeling of cyclotides as antimicrobial agents against Neisseria gonorrhoeae PorB porin protein: integration of docking, immune, and molecular dynamics simulations. Front Chem. 2024;12:1493165. https:\/\/doi.org\/10.3389\/fchem.2024.1493165.","journal-title":"Front Chem"},{"key":"519_CR40","doi-asserted-by":"publisher","unstructured":"Palmer N, Maasch JRMA, Torres MDT,\u00a0de la Fuente-Nunez C.\u00a0Molecular Dynamics for Antimicrobial Peptide Discovery. Infect Immun. 2021;89(4). https:\/\/doi.org\/10.1128\/IAI.00703-20.","DOI":"10.1128\/IAI.00703-20"},{"issue":"23","key":"519_CR41","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1093\/bioinformatics\/btw514","volume":"32","author":"LC Xue","year":"2016","unstructured":"Xue LC, Rodrigues JP, Kastritis PL, Bonvin AM, Vangone A. PRODIGY: a web server for predicting the binding affinity of protein-protein complexes. Bioinformatics. 2016;32(23):3676\u20138. https:\/\/doi.org\/10.1093\/bioinformatics\/btw514.","journal-title":"Bioinformatics"},{"issue":"1","key":"519_CR42","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2024.2415952","volume":"15","author":"R Wu","year":"2024","unstructured":"Wu R, Wu Y, Wu P, Li H, She P. Bactericidal and anti-quorum sensing activity of repurposing drug Visomitin against Staphylococcus aureus. Virulence. 2024;15(1):2415952. https:\/\/doi.org\/10.1080\/21505594.2024.2415952.","journal-title":"Virulence"},{"key":"519_CR43","doi-asserted-by":"publisher","unstructured":"He Y, Huang Y-Y, Xi L, Gelfand JA, Hamblin MR. Tetracyclines function as dual-action light-activated antibiotics. Plos One. 2018;13(5). https:\/\/doi.org\/10.1371\/journal.pone.0196485.","DOI":"10.1371\/journal.pone.0196485"},{"key":"519_CR44","doi-asserted-by":"publisher","unstructured":"Bravo-Santano N, Ellis JK, Mateos LM, Calle Y, Keun HC, Behrends V et al. Intracellular Staphylococcus aureus Modulates Host Central Carbon Metabolism To Activate Autophagy. mSphere. 2018;3(4). https:\/\/doi.org\/10.1128\/mSphere.00374-18.","DOI":"10.1128\/mSphere.00374-18"},{"key":"519_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-015-0376-x","volume":"15","author":"P Stiefel","year":"2015","unstructured":"Stiefel P, Schmidt-Emrich S, Maniura-Weber K, Ren Q. Critical aspects of using bacterial cell viability assays with the fluorophores SYTO9 and propidium iodide. BMC Microbiol. 2015;15:36. https:\/\/doi.org\/10.1186\/s12866-015-0376-x.","journal-title":"BMC Microbiol"},{"key":"519_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01353","volume":"11","author":"AM Qutb","year":"2020","unstructured":"Qutb AM, Wei F, Dong W. Prediction and characterization of cationic arginine-rich plant antimicrobial peptide SM-985 from teosinte (Zea mays ssp. mexicana). Front Microbiol. 2020;11:1353. https:\/\/doi.org\/10.3389\/fmicb.2020.01353.","journal-title":"Front Microbiol"},{"key":"519_CR47","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03615-25","author":"J Domagala","year":"2026","unstructured":"Domagala J, Jahanbakhsh S, Mendez AK, Pillar CM, Marra A, Hufnagel DA, et al. In vitro activity of MRS-2541, a novel MetRS inhibitor, against a selection of resistant gram-positive organisms associated with serious hospital infections. Microbiol Spectr. 2026. https:\/\/doi.org\/10.1128\/spectrum.03615-25.","journal-title":"Microbiol Spectr"},{"key":"519_CR48","doi-asserted-by":"publisher","unstructured":"Tripathi V, Morin B, Antelo Varela M, Loriol AA, Kurg K, Jakonia S et al. Microgeography of staphyloccoci in human tissue explains antibiotic failure. bioRxiv. 2025. https:\/\/doi.org\/10.1101\/2025.09.12.675782.","DOI":"10.1101\/2025.09.12.675782"},{"key":"519_CR49","doi-asserted-by":"publisher","unstructured":"Lorente-Torres B, Casta\u00f1era P, Ferrero H\u00c1, Fern\u00e1ndez-Mart\u00ednez S, Ocholi SA, Llano-Verdeja J et al. Streamlining Bacillus Strain Selection Against Listeria monocytogenes Using a Fluorescence-Based Infection Assay Integrated into a Multi-Tiered Validation Pipeline. Antibiotics (Basel). 2025;14(765). https:\/\/doi.org\/10.3390\/antibiotics14080765.","DOI":"10.3390\/antibiotics14080765"},{"issue":"4","key":"519_CR50","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/cmi.12233","volume":"16","author":"M Grosz","year":"2014","unstructured":"Grosz M, Kolter J, Paprotka K, Winkler AC, Schafer D, Chatterjee SS, et al. Cytoplasmic replication of Staphylococcus aureus upon phagosomal escape triggered by phenol-soluble modulin alpha. Cell Microbiol. 2014;16(4):451\u201365. https:\/\/doi.org\/10.1111\/cmi.12233.","journal-title":"Cell Microbiol"},{"key":"519_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-025-01200-y","author":"NG Oliveira Junior","year":"2025","unstructured":"Oliveira Junior NG, Souza CM, Buccini DF, Cardoso MH, Franco OL. Antimicrobial peptides: structure, functions and translational applications. Nat Rev Microbiol. 2025. https:\/\/doi.org\/10.1038\/s41579-025-01200-y.","journal-title":"Nat Rev Microbiol"},{"key":"519_CR52","doi-asserted-by":"publisher","unstructured":"Lazzaro BP, Zasloff M, Rolff J. Antimicrobial peptides: Application informed by evolution. Science. 2020;368(6490). https:\/\/doi.org\/10.1126\/science.aau5480.","DOI":"10.1126\/science.aau5480"},{"issue":"12","key":"519_CR53","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.tim.2021.03.007","volume":"29","author":"PK Jangir","year":"2021","unstructured":"Jangir PK, Ogunlana L, MacLean RC. Evolutionary constraints on the acquisition of antimicrobial peptide resistance in bacterial pathogens. Trends Microbiol. 2021;29(12):1058\u201361. https:\/\/doi.org\/10.1016\/j.tim.2021.03.007.","journal-title":"Trends Microbiol"},{"key":"519_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2022.107962","volume":"59","author":"Z Lai","year":"2022","unstructured":"Lai Z, Yuan X, Chen H, Zhu Y, Dong N, Shan A. Strategies employed in the design of antimicrobial peptides with enhanced proteolytic stability. Biotechnol Adv. 2022;59:107962. https:\/\/doi.org\/10.1016\/j.biotechadv.2022.107962.","journal-title":"Biotechnol Adv"},{"issue":"39","key":"519_CR55","doi-asserted-by":"publisher","first-page":"7030","DOI":"10.1002\/anie.201002906","volume":"49","author":"SS Puttamadappa","year":"2010","unstructured":"Puttamadappa SS, Jagadish K, Shekhtman A, Camarero JA. Backbone dynamics of cyclotide MCoTI-I free and complexed with trypsin. Angew Chem Int Ed Engl. 2010;49(39):7030\u20134. https:\/\/doi.org\/10.1002\/anie.201002906.","journal-title":"Angew Chem Int Ed Engl"},{"key":"519_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2025.07.019","author":"R Aunpad","year":"2025","unstructured":"Aunpad R, Thitirungreangchai T. Advancing antimicrobial peptides: overcoming challenges in the era of bacterial resistance. Biochimie. 2025. https:\/\/doi.org\/10.1016\/j.biochi.2025.07.019.","journal-title":"Biochimie"},{"issue":"20","key":"519_CR57","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1002\/cmdc.202000301","volume":"15","author":"R Kundu","year":"2020","unstructured":"Kundu R. Cationic amphiphilic peptides: synthetic antimicrobial agents inspired by nature. ChemMedChem. 2020;15(20):1887\u201396. https:\/\/doi.org\/10.1002\/cmdc.202000301.","journal-title":"ChemMedChem"},{"key":"519_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcsw.2024.100135","volume":"12","author":"Y Wang","year":"2024","unstructured":"Wang Y, Song M, Chang W. Antimicrobial peptides and proteins against drug-resistant pathogens. Cell Surf. 2024;12:100135. https:\/\/doi.org\/10.1016\/j.tcsw.2024.100135.","journal-title":"Cell Surf"},{"key":"519_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics15020136","author":"W Chumpol","year":"2026","unstructured":"Chumpol W, Lunha K, Jiemsup S, Yongkiettrakul S. In vitro synergistic effects of antibiotic combinations against multidrug-resistant Streptococcus suis from diseased pigs. Antibiotics (Basel). 2026. https:\/\/doi.org\/10.3390\/antibiotics15020136.","journal-title":"Antibiotics (Basel)"},{"key":"519_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1390765","volume":"15","author":"S Taheri-Araghi","year":"2024","unstructured":"Taheri-Araghi S. Synergistic action of antimicrobial peptides and antibiotics: current understanding and future directions. Front Microbiol. 2024;15:1390765. https:\/\/doi.org\/10.3389\/fmicb.2024.1390765.","journal-title":"Front Microbiol"},{"issue":"5","key":"519_CR61","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00228-015-1832-0","volume":"71","author":"J Tamargo","year":"2015","unstructured":"Tamargo J, Le Heuzey JY, Mabo P. Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide. Eur J Clin Pharmacol. 2015;71(5):549\u201367. https:\/\/doi.org\/10.1007\/s00228-015-1832-0.","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"519_CR62","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1021\/jacs.6b12565","volume":"139","author":"KV Mahasenan","year":"2017","unstructured":"Mahasenan KV, Molina R, Bouley R, Batuecas MT, Fisher JF, Hermoso JA, et al. Conformational dynamics in penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus, allosteric communication network and enablement of catalysis. J Am Chem Soc. 2017;139(5):2102\u201310. https:\/\/doi.org\/10.1021\/jacs.6b12565.","journal-title":"J Am Chem Soc"},{"issue":"14","key":"519_CR63","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.2174\/0929867322666150311150215","volume":"22","author":"I Acebr\u00f3n","year":"2015","unstructured":"Acebr\u00f3n I, Chang M, Mobashery S, Hermoso JA. The allosteric site for the nascent cell wall in penicillin-binding protein 2a: an Achilles\u2019 heel of methicillin-resistant Staphylococcus aureus. Curr Med Chem. 2015;22(14):1678\u201386.","journal-title":"Curr Med Chem"},{"key":"519_CR64","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.07454","volume":"4","author":"A Vangone","year":"2015","unstructured":"Vangone A, Bonvin AM. Contacts-based prediction of binding affinity in protein-protein complexes. Elife. 2015;4:e07454. https:\/\/doi.org\/10.7554\/eLife.07454.","journal-title":"Elife"},{"key":"519_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2023.101520","volume":"35","author":"TL Kirley","year":"2023","unstructured":"Kirley TL, Norman AB. Characterization and optimization of fluorescein isothiocyanate labeling of humanized h2E2 anti-cocaine mAb. Biochem Biophys Rep. 2023;35:101520. https:\/\/doi.org\/10.1016\/j.bbrep.2023.101520.","journal-title":"Biochem Biophys Rep"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00519-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00519-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00519-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:12:28Z","timestamp":1785521548000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-026-00519-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["519"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00519-z","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained from the\n                      Universidad de Le\u00f3n\n                      and the\n                      Junta de Castilla y Le\u00f3n\n                      (ETICA-ULE-060\u20132021, ETICA-ULE-003\u20132023, ETICA-ULE-043\u20132023) for BSL-2 work involving pathogens and genetically modified human cell lines.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Cesar de la Fuente-Nunez is a co-founder of, and scientific advisor, to Peptaris, Inc., provides consulting services to Invaio Sciences, and is a member of the Scientific Advisory Boards of Nowture S.L., Peptidus, European Biotech Venture Builder, the Peptide Drug Hunting Consortium (PDHC), ePhective Therapeutics, Inc., and Phare Bio. All other authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"120"}}